Field Service Experts of Securus Technologies receive the BICSI Installer 1 Certificates

Securus Technologies is a company the offers technology for the inmate communication industry. The company recently informed the public that 11 of its field experts had been accredited with certification that is internationally recognized. This shows that the corporation is dedicated to investing in its employees, products, services, and characters. The firm’s installation team will now be having top-notch capabilities.


The Building Industry Consulting Service International (BICSI) is an association of experts that facilitates the ICT sector. ICT consists of various fields, and they include data, project management, voice, audio & video, and electronic safety technologies. Members of the body and individuals who hold its credential have the skills to design, install, control, and uphold ICT programs. The developments are associated with trails, spaces, wireless-based systems, infrastructure, and distribution networks that are made of optical fiber and copper. The BICSI is used by about 23,000 ICT specialists for training, holding meetings, publications, and credentials in about 100 nations.


According to the operations, senior vice president of Secures Technologies, Danny de Hoyos, BICSI is the best institution that can train the company’s employees to meet the technology standards that are constantly developing. Offering in-job-training to the employees helps the company to provide top-notch solutions to the customers. The experts who were certified are highly experienced since they have been in Securus Technologies for about 15 years. The company believes in certification and the worth that it adds to the field service of the enterprise.



Securus Technologies is based in Dallas, Texas and the services that it provides are used by 3450 correctional facilities that have a population of about 1.2 million prisoners The largest client base of the company is located in North America. All solutions of the firm are dedicated to connecting the inmates with their family members. The services that it offers are public information, emergency response, management of incidents, biometric examination, investigation, information management, communication, and analysis of goods and services.


The Power & Excellence of Seattle Genetics

When you first think of the words domination and excellence, you’re probably associating this notion with sports. Fortunately, this notion is referring to the advancements in medicine. Cancer is all too prevalent in society now days. This deadly disease can affect many different organs in the body no matter the age, race, or creed of an individual. It may seem to be hopeless if you’re not caught up on current events, but there have been many advancements in this field over the past decade and there is one company that’s leading the way.

Seattle Genetics of Bothell, Washington is turning the tide and the fight against dangerous cancer. The company has been around since the late 90’s and is one of the most progressive thinking and acting Bio-Technology Institutions in the world. This bio-technology company is focused on developing and commercializing antibody based therapies that deal with the specifics of cancer. Their (ADCs) Antibody Drug Conjugates are specifically designed to neutralize and deliver cell-killing agents directly in cancerous cells. It’s like the old saying, ” you have to cut the snake’s head off to completely kill it.” That notion rings true the company’s (ADCs) as they are some of the researched most pharmaceuticals on the planet. Another bonus of these ” cancer cell killers” is that the patient shouldn’t experience any ill side effects from the treatments unlike Chemotherapy. The company has a continued approach to remaining the best in an industry that’s full of hopes and dreams. The future seems to be looking bright as Seattle Genetics has many new products and projects in the pipeline. To have such a strong presence and success, you have to have a strong leader and Seattle Genetics’ Dr. Clay Siegell is leading this brand through the 21st Century. The highly accomplished doctor/scientist has up to 20 years in cancer development and research as well as worked for numerous prominent industry leading corporations.

The future is now and Seattle Genetics is leading the way in the fight against deadly cancerous diseases.

Learn more about Clay Siegall:

Laidlaw & Company Gets Additional Charges from Relmada Therapeutics

In December, 2015 Laidlaw & Company was charged with violating financial regulations in their dealings with Relmada Therapeutics, a clinical-stage pharmaceutical company. Laidlaw was charged with releasing false and misleading information about Relmada, which damaged shareholder value. Laidlaw had served as the primary investment banker for the company’s prior offerings and other investment banking services. Laidlaw was in effect, trying to manipulate the company’s share price in order to take control of the company.

Laidlaw has a long history of acting inappropriately, violating securities laws and financial regulations. Laidlaw formerly operated as Sands Brothers International. They were incorporated in England, but operate primarily in New York. For the two years between 2007 and 2009, the received more than 60 customer complaints and claims that they damaged the value of their clients. They were also sanctioned by FINRA for not reporting the complaints.

Laidlaw was charged with failing to establish and follow procedures for compliance with anti-money laundering and email retention. They created inaccurate communications records with clients, and failed to implement adequate supervisory controls within the company. The two principals, Matthew Eitner and James Ahern have a poor history of looking after their client’s best interests. They do not seem to have gotten a handle on the fact that the securities industry is based on following a set of rigid regulations and rules, which applies to them as well.